检索结果 - Garth Nicholas

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
    Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial

    Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial 由 Steven A. Toms, Chae‐Yong Kim, Garth Nicholas, Zvi Ram

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Are Clinical Trial Eligibility Criteria an Accurate Reflection of a Real-World Population of Advanced Non-Small-Cell Lung Cancer Patients?

    Are Clinical Trial Eligibility Criteria an Accurate Reflection of a Real-World Population of Advanced Non-Small-Cell Lung Cancer Patients? 由 Khalid Al-Baimani, Hannah Jonker, T. Zhang, Glenwood D. Goss, Scott A. Laurie, Garth Nicholas, Paul Wheatley‐Price

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada

    Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada 由 Kevin ten Haaf, Martin C. Tammemägi, Susan J. Bondy, Carlijn M. van der Aalst, Sumei Gu, S. Elizabeth McGregor, Garth Nicholas, Harry J. de Koning, Lawrence Paszat

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

    Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small... 由 Janessa Laskin, Garth Nicholas, Christopher Lee, Barbara J. Gitlitz, Mark Vincent, Yvon Cormier, Joe Stephenson, Yee Ung, Rachel E. Sanborn, Bryn Pressnail, F. Warren Nugent, John Nemunaitis, Martin Gleave, Nevin Murray, Desirée Hao

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group

    Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group 由 Scott A. Laurie, Ashish Gupta, Quincy Chu, Christopher W. Lee, W. Morzycki, Ronald Feld, Alison H. Foo, Jean M. Seely, John R. Goffin, Francis Laberge, Nevin Murray, S. A. Rao, Garth Nicholas, Janessa Laskin, Tony Reiman, Delia Sauciuc, Lesley Seymour

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort

    Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohort 由 Niloofar Taghizadeh, Alain Tremblay, Sonya Cressman, Stuart Peacock, Annette McWilliams, Paul MacEachern, Michael R. Johnston, John R. Goffin, Glen Goss, Garth Nicholas, Simon Martel, Francis Laberge, Rick Bhatia, Geoffrey Liu, Heidi Schmidt, Sukhinder Atkar-Khattra, Ming‐Sound Tsao, Martin C. Tammemägi, Stephen Lam

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Canadian Consensus: Oligoprogressive, Pseudoprogressive, and Oligometastatic Non-Small-Cell Lung Cancer

    Canadian Consensus: Oligoprogressive, Pseudoprogressive, and Oligometastatic Non-Small-Cell Lung Cancer 由 Scott A. Laurie, Shantanu Banerji, Normand Blais, Stephanie Yasmin Brule, Parneet Cheema, Patrick Cheung, Nathalie Daaboul, Desirée Hao, Vera Hirsh, Rosalyn A. Juergens, Janessa Laskin, Natasha B. Leighl, Robert M. MacRae, Garth Nicholas, David Roberge, J. Rothenstein, David J. Stewart, Ming‐Sound Tsao

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results

    ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results 由 Valsamo Anagnostou, Cheryl Ho, Garth Nicholas, Rosalyn A. Juergens, Adrian G. Sacher, Andrea S. Fung, Paul Wheatley‐Price, Scott A. Laurie, Benjamin Levy, Julie R. Brahmer, Archana Balan, Noushin Niknafs, Egor Avrutin, Liting Zhu, Mark Sausen, Penelope A. Bradbury, Jill O’Donnell-Tormey, Pierre Olivier Gaudreau, Keyue Ding, Janet Dancey

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma

    Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma 由 Roger Stupp, Sophie Taillibert, Andrew A. Kanner, William L. Read, David M. Steinberg, Benoît Lhermitte, Steven A. Toms, Ahmed Idbaïh, Manmeet S. Ahluwalia, Karen Fink, Francesco Di Meco, Frank S. Lieberman, Jay‐Jiguang Zhu, Giuseppe Stragliotto, David D. Tran, Steven Brem, Andreas F. Hottinger, Eilon D. Kirson, Gitit Lavy-Shahaf, Uri Weinberg, Chae‐Yong Kim, Sun-Ha Paek, Garth Nicholas, Jordi Bruna, Hal W. Hirte, Michael Weller, Yoram Palti, Monika E. Hegi, Zvi Ram

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial

    Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial 由 Patrick Roth, Thierry Gorlia, Jaap C. Reijneveld, Filip De Vos, Ahmed Idbaïh, Jean‐Sébastien Frénel, Émilie Le Rhun, Juan Manuel Sepúlveda-Sánchez, James Perry, Giuseppina Laura Masucci, Pierre Frères, Hal W. Hirte, Clemens Seidel, Annemiek Walenkamp, Slávka Lukacova, Paul Meijnders, Andre Blais, François Ducray, Vincent Verschaeve, Garth Nicholas, Carmen Balañá, Daniela A. Bota, Matthias Preusser, Sarah Nuyens, F. Dhermain, Martin J. van den Bent, Chris J. O’Callaghan, Maureen Vanlancker, Warren Mason, Michael Weller

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Probability of Cancer in Pulmonary Nodules Detected on First Screening CT

    Probability of Cancer in Pulmonary Nodules Detected on First Screening CT 由 Annette McWilliams, Martin C. Tammemägi, John R. Mayo, Heidi Roberts, Geoffrey Liu, Kam Soghrati, Kazuhiro Yasufuku, Simon Martel, Francis Laberge, Michel Gingras, Sukhinder Atkar-Khattra, Christine D. Berg, Ken Evans, Richard J. Finley, John Yee, John C. English, Paola Nasute, John R. Goffin, Serge Puksa, Lori Stewart, Scott Tsai, Michael R. Johnston, Daria Manos, Garth Nicholas, Glenwood Goss, Jean M. Seely, Kayvan Amjadi, Alain Tremblay, Paul Burrowes, Paul MacEachern, Rick Bhatia, Ming‐Sound Tsao, Stephen Lam

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency

    The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency 由 Sonya Cressman, Stuart Peacock, Martin C. Tammemägi, William K. Evans, Natasha B. Leighl, John R. Goffin, Alain Tremblay, Geoffrey Liu, Daria Manos, Paul MacEachern, Rick Bhatia, Serge Puksa, Garth Nicholas, Annette McWilliams, John R. Mayo, John Yee, John C. English, Reka Pataky, Emily McPherson, Sukhinder Atkar-Khattra, Michael R. Johnston, Heidi Schmidt, Frances A. Shepherd, Kam Soghrati, Kayvan Amjadi, Paul Burrowes, Christian Couture, Harmanjatinder S. Sekhon, Kazuhiro Yasufuku, Glenwood Goss, Diana N. Ionescu, David Hwang, Simon Martel, Don D. Sin, Wan C. Tan, Stefan J. Urbanski, Zhaolin Xu, Ming‐Sound Tsao, Stephen Lam

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Resource Utilization and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography in Canada

    Resource Utilization and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography in Canada 由 Sonya Cressman, Stephen Lam, Martin C. Tammemägi, William K. Evans, Natasha B. Leighl, Dean A. Regier, Corneliu Bolbocean, Frances A. Shepherd, Ming‐Sound Tsao, Daria Manos, Geoffrey Liu, Sukhinder Atkar-Khattra, Ian Cromwell, Michael R. Johnston, John R. Mayo, Annette McWilliams, Christian Couture, John C. English, John R. Goffin, David Hwang, Serge Puksa, Heidi Roberts, Alain Tremblay, Paul MacEachern, Paul Burrowes, Rick Bhatia, Richard J. Finley, Glenwood Goss, Garth Nicholas, Jean M. Seely, Harmanjatinder S. Sekhon, John Yee, Kayvan Amjadi, Jean‐Claude Cutz, Diana N. Ionescu, Kazuhiro Yasufuku, Simon Martel, Kamyar Soghrati, Don D. Sin, Wan C. Tan, Stefan J. Urbanski, Zhaolin Xu, Stuart Peacock

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)

    A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE) 由 Timothy F. Cloughesy, Andrew Brenner, John de Groot, Nicholas Butowski, Leor Zach, Jian L. Campian, Benjamin M. Ellingson, Laurence S. Freedman, Yaël Cohen, Noa Lowenton‐Spier, Tamar Rachmilewitz Minei, Shifra Fain Shmueli, Patrick Y. Wen, Nicholas G. Avgeropoulos, J.T. Beck, Tara Benkers, Felix Bokstein, Andrew Brenner, Eric Burton, Nicholas Butowski, Jian L. Campian, José Antonio Ortega Carrillo, Timothy F. Cloughesy, John de Groot, Paula de Robles, Jan Drappatz, I. Dunbar, Karen Fink, Morris D. Groves, Xiaosi Han, Hormigo Adila, Randy Jensen, Agnieszka Kowalska, Pyriya Kumthekar, Mijung Lee, Glenn J. Lesser, Alexander Lossos, Rimas V. Lukas, David Macdonald, Aaron Mammoser, László Mechtler, Nimish Mohile, Seema Nagpal, Garth Nicholas, Teri Kreisl, Edward Pan, Scott Peak, Michael Pearlman, James Perry, Richard A. Peterson, David Piccioni, H. Ian Robins, Lara Kunschner Ronan, Michael Salacz, David Schiff, David D. Tran, Leor Zach, Tzahala Tzuk-Shina, Tobias Walbert, Patrick Y. Wen, Shlomit Youst

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

    Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial 由 Mrinal M. Gounder, Albiruni Abdul Razak, Neeta Somaiah, Sant P. Chawla, Javier Martín‐Broto, Giovanni Grignani, Scott M. Schuetze, Bruno Vincenzi, Andrew J. Wagner, Bartosz Chmielowski, Robin L. Jones, Richard F. Riedel, Silvia Stacchiotti, Elizabeth T. Loggers, Kristen N. Ganjoo, Axel Le Cesne, Antoîne Italiano, Xavier García del Muro, Melissa Burgess, Sophie Piperno‐Neumann, Christopher W. Ryan, Mary F. Mulcahy, Charles Forscher, Nicolas Penel, Scott H. Okuno, Anthony Elias, Lee Hartner, Tony Philip, Thierry Alcindor, Bernd Kasper, Peter Reichardt, Lore Lapeire, Jean‐Yves Blay, Christine Chevreau, Claudia Maria Valverde Morales, Gary K. Schwartz, James L. Chen, Hari A. Deshpande, Elizabeth J. Davis, Garth Nicholas, Stefan Gröschel, Helen Hatcher, Florence Duffaud, Antonio Casado, Roberto Díaz Beveridge, Giuseppe Badalamenti, Mikael Eriksson, Christian F. Meyer, Margaret von Mehren, Brian A. Van Tine, Katharina S. Götze, F Mazzeo, Alexander Yakobson, Aviad Zick, Alexander T.J. Lee, Anna Estival, Andrea Napolitano, Mark A. Dickson, Dayana Michel, Changting Meng, Lingling Li, Jianjun Liu, Osnat Ben‐Shahar, Dane R. Van Domelen, Christopher J. Walker, Hua Chang, Yosef Landesman, Jatin J. Shah, Sharon Shacham, Michael Kauffman, Steven Attia

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance

    Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance 由 Carol Durno, Ayse B. Ercan, Vanessa Bianchi, Melissa Edwards, Melyssa Aronson, Melissa A. Galati, Eshetu G. Atenafu, Gadi Abebe‐Campino, Abeer Al-Battashi, Musa Alharbi, Vahid Fallah Azad, Hagit Baris, Donald Basel, Raymond Bedgood, Anne Bendel, Shay Ben‐Shachar, Deborah T. Blumenthal, Maude L. Blundell, Miriam Bornhorst, Annika Bronsema, Elizabeth Cairney, Sara Rhode, Shani Caspi, Aghiad Chamdin, Stefano Chiaravalli, Shlomi Constantini, Bruce Crooks, Anirban Das, Rina Dvir, Roula Farah, William D. Foulkes, Z Frenkel, Bailey Gallinger, Sharon L. Gardner, David Gass, Mithra Ghalibafian, Catherine Gilpin, Yael Goldberg, Catherine Goudie, Syed Ahmer Hamid, Heather Hampel, Jordan R. Hansford, Craig Harlos, Nobuko Hijiya, Saunders Hsu, Junne Kamihara, Rejin Kebudi, Jeffrey Knipstein, Carl Koschmann, Christian P. Kratz, Valérie Larouche, Álvaro Lassaletta, Scott Lindhorst, Simon C. Ling, Michael P. Link, Rebecca Loret De Mola, Rebecca C. Luiten, Michal Lurye, Jamie L. Maciaszek, Vanan MagimairajanIssai, Ossama Maher, Maura Massimino, Rose B. McGee, Naureen Mushtaq, Gary Mason, Monica Newmark, Garth Nicholas, Kim E. Nichols, Theodore Nicolaides, Enrico Opocher, Michael Osborn, Benjamin Oshrine, Rachel Pearlman, Daniel Pettee, Jan Rapp, Mohsin Rashid, Alyssa Reddy, Lara Reichman, Marc Remke, Gabriel Robbins, Sumita Roy, Magnus Sabel, David Samuel, Isabelle Scheers, Kami Wolfe Schneider, Santanu Sen, Duncan Stearns, David Sumerauer, Carol J. Swallow, Leslie M. Taylor, Gregory A. Thomas, Helen Toledano, Patrick Tomboc, An Van Damme, Ira Winer, Michal Yalon, Yi‐Yen Lee, Michal Zápotocký, Shayna Zelcer, David S. Ziegler

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

    Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial 由 Michael Weller, Nicholas Butowski, David Tran, Lawrence D. Recht, Michael Lim, Hal W. Hirte, Lynn S. Ashby, Laszlo Mechtler, Samuel Goldlust, Fábio M. Iwamoto, Jan Drappatz, Donald M. O’Rourke, Mark Wong, Mark G. Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, Christopher D. Turner, Michael Yellin, Tibor Keler, Thomas A. Davis, Roger Stupp, John H. Sampson, Nicholas Butowski, Jian L. Campian, Lawrence D. Recht, Michael Lim, Lynn S. Ashby, Jan Drappatz, Hal W. Hirte, Fábio M. Iwamoto, Laszlo Mechtler, Samuel Goldlust, Kevin Becker, Gene H. Barnett, Garth Nicholas, Annick Desjardins, Tara Benkers, Naveed Wagle, Morris D. Groves, Santosh Kesari, Zsolt Horváth, Ryan Merrell, Richard Curry, James O’Rourke, David M. Schuster, Mark Wong, Maciej M. Mrugała, Randy Jensen, John Trusheim, Glenn J. Lesser, Karl Bélanger, Andrew E. Sloan, Benjamin Purow, Karen Fink, Jeffrey J. Raizer, Michael Schulder, Suresh Nair, Scott Peak, James Perry, Alba A. Brandes, Michael Weller, Nimish Mohile, Joseph Landolfi, Jon Olson, Gaetano Finocchiaro, Ross Jennens, Paul DeSouza, Bridget A. Robinson, Marka R. Crittenden, Kent C. Shih, Alexandra Flowers, Shirley Ong, Jennifer Connelly, Costas G. Hadjipanayis, Pierre Giglio, Frank E. Mott, David Mathieu, N. Lessard, Sanchez Juan Sepulveda, József Lövey, Helen Wheeler, Po-Ling Inglis, Claire Hardie, Daniela A. Bota, Maciej S. Lesniak, Jana Portnow, Bruce Frankel, Larry Junck, Reid C. Thompson, Lawrence Berk, John Paul McGhie, David Macdonald, Frank Saran, Riccardo Soffietti, Deborah T. Blumenthal, Sá Barreto Costa Marcos André de, Anna K. Nowak

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: